1Davidson B,Berner A,Nesland JM,et al.E-cadherin andα-,β-,andγ-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions[J].J Pathol,2000,192(21):460-469
2Sundfeldt K,Piotkewitz Y,Ivarsson K,et al.E-cadherin expression in human epithelial ovarian cancer and normal ovary[J].Int J Cancer,1997,74(3):275-280
1Sundfeldt K, Piontkewitz Y, Ivarsson K, et al .E-cadherin expression in human epithelial ovarian cancer and normal ovary.lnt J Cancer, 1997,74:275-80.
2Ong A, Satah L, Bandiera M, et al .An ovarian adenocarcinoma line derived from SV40/E-cadherin-transfected normal human ovarian surface epithelium. Int J Cancer, 2000, 85,430- 7.
3Birehmeier W. E-cadherin as a tumour(invasion) suppressor gene. BioEssays, 2001,17(2 ) : 97 - 9.
4Umbas R, Schalken JA, Aalder TW, et al .Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer .Cancer Res, 1992, 52: 5104-9.
5Rimm D, Morrow JS.Molecular cloning of human E- cadherin suggests a novel subdivision of the cadherin superfamily .Biochem Biophys Res Commum, 1994, 200(3):1754-61.
6Gadducci A, Ferdeghini M, Cosio S, et al .Preoperative serum E-cadherin assays in patients with ovarian carcinoma. Anticancer Res, 1999,19: 769-72.
7Davies BR,Worsley SD, Ponder BA .Expression of E- cadherin,tz-catenin and ~-catenin in normal ovarian surface epithelium and epithelial ovarian cancers. Histopathology, 1998,32: 69 - 80.
8Darai E,Scoazec JY,Walker-Combrouze F,et al. Expression of cadherins in benign, borderline, and malignant ovarian epithelial tumors: a clinicopathologic study of 60 cases.Hum Patbol,1997, 28: 922-8.
9Inoue M,Ogawa H,Miyata M,et al .Expression of E- cadherin in normal, benign, and malignant tissues of female genital organs .Am J Clin Pathol, 1992,98: 76-8.
10Wong AST, Maines-Bandiera SL, Rosen B, et al. Constitutive and conditional cadherin expression in cultured human ovarian surface epithelium: influence of family history of ovarian cancer. Int J Cancer, 1999,81 : 180- 8.
1Watanabe T, Hashimoto T, Sugino T,et al. Production of ILl-beta by ovarian cancer cells induces mesothelial cell betal-integrin expression facilitating p.eritoneal dissemina- tion[J]. J Ovarian Re s, 2012,5 (1) : 1-13.
2Gavalas NG,Liontos M,Trachana SP. Angiogenesis-related pathways in the pathogenesis of ovarian cancer [J]. Int J Mol Sci,2013,14(8), 15885-15909.
3Petrillo M,Scambia G,Ferrandina G. Novel targets for VEGF-independent anti-angiogenic drugs [J]. Expert Opin Invest Drugs, 2012,21 (4) : 451-472.
4Zhu M, Fejzo MS, Anderson L, et al. Periostin promotes o- varian cancer angiogenesis and metastasis[J]. Gyneeol On- col, 2010,119(2) : 337-344.
5Nieman KM, Romero IL,Van Houten B,et al. Adipose tis- sue and adipocytes support tumorigenesis and metastasis [J].Biochim Biophys Acta,2013,1831(10): 1533-1541.
6Wang ZQ,Keita M,Bachvarova M,et all Inhibition of RUNX2 transcriptional activity blocks the proliferation, migration and invasion of epithelial ovarian carcinoma cells[J].PloS One, 2013,8(10): 1-15.
7Keita M,Wang ZQ,Pelletier JF,et al. Global methylation profiling in serous ovarian cancer is indicative for distinct aberrant DNA methylation signatures associated with tu- mor aggressiveness and disease progression[J]. Gyneeol Oncol, 2013,128(2) : 356-363.
8Keita M,Bachvarova M,Morin C,et al. The RUNX1 tran- scription factor is expressed in serous epithelial ovarian carcinoma and contributes to cell proliferation,migration and invasion[J].Cell Cycle, 2013,12(6) : 972-986.
9Planaguma J,Liljestrom M,Alameda F,et al. Matrix met- alloproteinase-2 and matrix metalloproteinase-9 codis- tribute with transcription factors RUNXI/AML1 and ETV5/ERM at the invasive front of endometrial and ovari- an carcinoma[J].Hum Pathol, 2011,42(1):57-67.
10Niu DF,Kondo T,Nakazawa T,et al. Transcription factor Runx2 is a regulator of epithelial-mesenchymal transition and invasion in thyroid carcinomas[J]. Lab Invest,2012, 92(8) : 1181-1190.
